BioLamina raised €17M in funding in a round led by Lauxera Capital Partners, with participation from Bure Equity, Northislet and BioLamina’s founders.

Biotech Health services Manufacturing

Investments

17 August 2023

BioLamina (company)

Biotech Health services Manufacturing

Total investments received (USD): 18.55m

Round value (USD): 18.55m

Round investors: Lauxera Capital Partners Bure Equity North Islet

Industry: Biotech Health services Manufacturing

Agriculture Biotech Food Industry Manufacturing

Investments 10 February 2024

Energy Financial Services Marketplace

Investments 09 February 2024

AI (big data) Health services Manufacturing Software Services

Investments 03 February 2024

Health services Manufacturing Pharma Software Services

Investments 03 February 2024

Financial Services

Investments 31 January 2024